FGF2 and cancer: BMPs are thought to induce endothelial mesenchymal transformation (EMT) in cancer cells through SMAD and non-SMAD signaling pathways [17], while fibroblast growth factor-2 (FGF-2) has been revealed to mediated EMT in corneal endothelial cells [18].